Literature DB >> 21932611

Pulmonary hypertension and reopening of the ductus arteriosus in an infant treated with diazoxide.

Fatma Demirel1, Sevim Unal, I Ilker Çetin, Ihsan Esen, Aslihan Arasli.   

Abstract

Diazoxide is the main therapeutic agent for persistent hyperinsulinemic hypoglycemia. Generally, it is tolerated well, but rarely it can cause severe life-threatening complications. We report a neonate who was treated with diazoxide for hyperinsulinemic hypoglycemia. On the 6th day of the treatment we observed sepsis-mimicking symptoms, mild pulmonary hypertension, and re-opening of the ductus arteriosus. All these findings resolved dramatically shortly after discontinuation of treatment. To our knowledge, this is the first reported case of re-opening of the ductus arteriosus due to diazoxide toxicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21932611     DOI: 10.1515/jpem.2011.238

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  14 in total

Review 1.  Pulmonary Hypertension and ATP-Sensitive Potassium Channels.

Authors:  Conor McClenaghan; Kel Vin Woo; Colin G Nichols
Journal:  Hypertension       Date:  2019-05-28       Impact factor: 10.190

Review 2.  Novel drug targets for ductus arteriosus manipulation: Looking beyond prostaglandins.

Authors:  Elaine L Shelton; Gautam K Singh; Colin G Nichols
Journal:  Semin Perinatol       Date:  2018-05-10       Impact factor: 3.300

3.  Liver injury may increase the risk of diazoxide toxicity: a case report.

Authors:  Emir Tas; Burhanuddin Mahmood; Luigi Garibaldi; Mark Sperling
Journal:  Eur J Pediatr       Date:  2015-01-25       Impact factor: 3.183

Review 4.  Development of Pulmonary Hypertension During Treatment with Diazoxide: A Case Series and Literature Review.

Authors:  Matthew R Timlin; Alexander B Black; Heather M Delaney; Renée I Matos; Candace S Percival
Journal:  Pediatr Cardiol       Date:  2017-06-22       Impact factor: 1.655

Review 5.  Kir6.1 and SUR2B in Cantú syndrome.

Authors:  Conor McClenaghan; Colin G Nichols
Journal:  Am J Physiol Cell Physiol       Date:  2022-07-25       Impact factor: 5.282

Review 6.  Update on neonatal hypoglycemia.

Authors:  Paul J Rozance
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-02       Impact factor: 3.243

Review 7.  Current Status of Childhood Hyperinsulinemic Hypoglycemia in Turkey.

Authors:  Zeynep Şıklar; Merih Berberoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-05-16

Review 8.  Congenital Hyperinsulinism: Diagnosis and Treatment Update.

Authors:  Hüseyin Demirbilek; Khalid Hussain
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-12-27

Review 9.  Congenital hyperinsulinism: current status and future perspectives.

Authors:  Tohru Yorifuji
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-06-30

10.  The danger of diazoxide in the neonatal intensive care unit.

Authors:  Jay Desai; Logan Key; Alyson Swindall; Kan Gaston; Ajay J Talati
Journal:  Ther Adv Drug Saf       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.